NTF3 and brain neoplasm: Similarly, the specific activation of neurotrophic factors, receptors TrkB and TrkC by their ligands neurotrophin 3 (NT3) and brain-derived neurotrophic factor (BDNF) via Akt and ERK pathways, promotes the survival of brain tumour-initiating cells [4].